Skip to main content
Netramark Holdings Inc. logo

Netramark Holdings Inc. — Investor Relations & Filings

Ticker · AIAI ISIN · CA64119M1059 LEI · 391200VOK8WHERIX0Q06 CSE Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 336 across all filing types
Latest filing 2021-08-10 M&A Activity
Country CA Canada
Listing CSE AIAI

About Netramark Holdings Inc.

https://www.netramark.com/

Netramark Holdings Inc. develops and deploys advanced Artificial Intelligence (AI) and Machine Learning (ML) solutions specifically for the pharmaceutical industry, focusing on optimizing clinical trial design and outcomes. Its core product, NetraAI, is an AI platform powered by the proprietary Attractor AI algorithm. NetraAI analyzes complex, multimodal clinical trial datasets to uncover hidden patient correlations and causal factors, providing high clarity and explainability. The platform delivers AI-powered insights to trial sponsors, clinical research organizations, and biotechnology companies. These insights are used to inform protocol design, identify optimal patient subpopulations, determine effective dosage, enhance enrichment strategies, and improve inclusion/exclusion criteria, thereby increasing effect sizes and minimizing clinical trial risks.

Recent filings

Filing Released Lang Actions
News release - English.pdf
M&A Activity Classification · 95% confidence The document is a press release announcing that Nurosene Health Inc. has entered into a non-binding letter of intent to acquire NetraMark Corp. It details the terms of the proposed acquisition, including purchase price, payment method, and conditions precedent. The document includes background information on both companies, forward-looking statements, and contact information. There are no financial statements, audit reports, or detailed financial performance data included. The document is primarily an announcement of a transaction proposal rather than a full merger filing or a financial report. It does not contain transcript content, regulatory certifications, or voting results. Given the nature of the content as an announcement of a proposed acquisition and the absence of detailed merger filings or financial statements, the most appropriate classification is M&A Activity (TAR). The document length (9260 characters) supports it being a full announcement rather than a brief notice or report publication announcement.
2021-08-10 English
News release - English.pdf
Regulatory Filings
2021-08-03 English
News release - English.pdf
Regulatory Filings
2021-07-26 English
News release - English.pdf
Regulatory Filings
2021-07-06 English
News release - English.pdf
Regulatory Filings
2021-07-02 English
News release - English.pdf
Regulatory Filings
2021-06-30 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.